Can a 19‑year‑old patient be prescribed Wellbutrin (bupropion)?

Can a 19-Year-Old Take Wellbutrin?

Yes, a 19-year-old can be prescribed Wellbutrin (bupropion), though it requires careful consideration of the indication, contraindications, and close monitoring for neuropsychiatric adverse effects.

FDA Approval Status and Off-Label Use

Bupropion is not FDA-approved for any indication in patients under 18 years of age 1. However, at 19 years old, this patient falls into the young adult category where bupropion has established use for depression (FDA-approved in the 1980s) and smoking cessation (approved in 1997) 2. The lack of pediatric approval is a regulatory distinction rather than a safety prohibition for young adults.

Clinical Indications in Young Adults

Depression

Depression is the most common indication for bupropion in young adults (47% of prescriptions in the 18-29 age group) 3. For young adults with major depressive disorder, bupropion should be selected based on its favorable adverse effect profile—particularly lower rates of sexual dysfunction and weight gain compared to SSRIs 4, 5. The American College of Physicians recommends choosing second-generation antidepressants based on adverse effect profiles, cost, and patient preferences, as efficacy does not differ significantly among agents 4.

Other Indications

• Smoking cessation: Well-established use with documented efficacy 6
• ADHD: Second most common indication in young adults (12% of prescriptions) 3
• Weight management: Used in combination with naltrexone for obesity treatment 2, 7

Critical Safety Considerations

Black Box Warning: Neuropsychiatric Effects

Monitor closely for development or worsening of depression, suicidal ideation/behavior, hostility, and agitation—particularly in the first 1-2 months of treatment 6, 4. This risk is highest during initial treatment and requires assessment within 1-2 weeks of initiation 4. The 2025 American Thoracic Society guideline emphasizes that despite very low certainty evidence, the panel judged potential benefits outweigh risks in adolescents and young adults when properly monitored 1.

Absolute Contraindications

Do not prescribe bupropion if the patient has:

• Seizure disorder or conditions increasing seizure risk (stroke, brain metastases, head trauma) 6, 1
• Current or prior bulimia or anorexia nervosa (higher seizure incidence) 1
• Concurrent MAOI use (within 14 days) 7
• Abrupt discontinuation of alcohol or benzodiazepines (lowers seizure threshold)

Relative Cautions

• Closed-angle glaucoma 6
• Uncontrolled hypertension (bupropion can increase blood pressure) 7
• History of psychosis or bipolar disorder (may precipitate manic episodes)

Dosing Strategy

Start low and titrate slowly to minimize adverse effects:

1. Initial dose: 150 mg once daily in the morning (sustained-release formulation) 8, 7
2. Titration: After 3-4 days, increase to 150 mg twice daily if tolerated 8
3. Maximum dose: 300 mg/day (given as 150 mg twice daily) 7
4. Extended-release formulation: Can use 150 mg XL once daily, increasing to 300 mg XL once daily after 4 days 9

The extended-release 24-hour 150 mg formulation is most commonly prescribed (62% of initiations) and demonstrates favorable pharmacokinetics in young patients 3, 10.

Monitoring Protocol

Initial Phase (Weeks 1-8)

• Week 1-2: Assess for suicidal ideation, agitation, irritability, unusual behavioral changes 4
• Week 4-6: Evaluate therapeutic response; if inadequate, consider dose adjustment 4
• Week 6-8: If no response, modify treatment strategy 4

Ongoing Monitoring

• Blood pressure: Check regularly, especially if hypertension risk factors present 7
• Seizure precautions: Educate patient to avoid alcohol excess, maintain regular sleep, avoid other medications that lower seizure threshold
• Allergic reactions: Monitor for delayed hypersensitivity (pruritus, urticaria) which can occur 2-4 weeks after initiation 11

Common Adverse Effects

Most frequent side effects (generally mild and dose-dependent):

• Insomnia (4-10%) - give second dose before 3 PM 8, 5
• Dry mouth (20%) 7
• Headache (8-16%) 7
• Nausea (less common than SSRIs) 5
• Irritability (9.4% in adolescent studies) 12

Advantages over SSRIs:

• Lower sexual dysfunction rates (significant consideration in young adults) 4, 5
• No weight gain (may cause modest weight loss) 7
• Activating properties may improve apathy and energy 8

Treatment Duration

• First episode depression: Minimum 4 months after achieving remission 5
• Recurrent depression: Consider prolonged treatment 5
• Smoking cessation: 7-12 weeks, may extend to 6 months-1 year 6

Approximately 39-45% of patients remain on bupropion for at least 6 months, with variation by indication 3.

Special Populations

Concurrent Medication Use

• 22% of bupropion initiators are on concurrent SSRI treatment 3, suggesting combination therapy is common practice
• CYP2D6 interactions: Bupropion inhibits CYP2D6, increasing levels of drugs metabolized by this pathway (e.g., desipramine levels increase 5-fold) 9
• Avoid with MAOIs: 14-day washout required 7

Comorbid Conditions

In young adults with comorbid depression and ADHD, bupropion may address both conditions simultaneously, though evidence is stronger for depression 13. For comorbid anxiety, use caution—bupropion's stimulating properties can exacerbate anxiety in some patients, though it may reduce anxiety symptoms in others with mild-to-moderate anxiety 14.

Clinical Pearls

• Bupropion is well-tolerated in young adults with discontinuation rates due to adverse effects lower than many alternatives 5
• Consider bupropion first-line when sexual dysfunction or weight gain are particular concerns 4
• Avoid in agitated patients due to activating properties 8
• The active metabolite hydroxybupropion likely contributes significantly to therapeutic effects, with levels 16 times higher than parent compound 10
• Overdose risk: Bupropion carries higher toxicity in overdose than SSRIs, with neurologic and cardiac effects—important consideration in patients with suicidal ideation 15